A Phase 3b, Multicenter, Open-Label Extension Study of Phenoptin in Subjects with Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006

Registry ID

EUCTR2006-000839-10

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

BioMarin Pharmaceutical Inc.

Start date

2006-06-19

Completion date

2009-04-28

Last update

2026-08-16

Conditions

• Fenilcetonuria (PKU)
• phenylketonuria
• Phenylketonuria (PKU)

Summary

The objective of this study is to evaluate the safety of long-term treatment with Phenoptin in subjects with phenylketonuria (PKU) who participated in Phase 3 clinical studies with Phenoptin.

Locations

• , , Germany
• , , Italy
• , , Spain
• , , UK
• , , Ireland

Related clinical trials

• Prevalence and Determinants of Obesity in PKU Patients
• A Study of MZE782 in Adults With PKU
• A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)
• Multiomics Approach in Adult Patients With Phenylketonuria
• A Long-Term Study of JNT-517 in Participants With Phenylketonuria
• A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

View on source registry